课题基金 / 基金详情

Development of a novel bone formation therapy by inhibition of the calponin gene expression

Development of a novel bone formation therapy by inhibition of the calponin gene expression
通过抑制钙调蛋白基因表达开发新型骨形成疗法
批准号:
12557128
负责人:
TAKAHASHI Katsuhito
金额:
$8.19万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

TAKAHASHI Katsuhito的其他基金

相似基金

相关文献

中文摘要
翻译
通过向培养基中加入小鼠钙调蛋白h1的反义寡核苷酸来增强重组人BMP-2(40 ng/ml)诱导的成肌细胞向成骨细胞的分化。用胰蛋白酶消化法从大腿肌肉中制备成肌细胞。设计并合成了小鼠钙调蛋白h1序列的反义寡核苷酸(18聚体),该序列包括起始密码子。80 μg/ml的反义寡核苷酸处理48小时后,Calponin h1 mRNA的表达明显降低,碱性磷酸酶的表达显示有32.4±3.9%的细胞分化为成骨细胞。我们还证明了骨折后48小时,通过用pluronic F127凝胶局部递送反义寡聚DNA,实验性骨折的加速愈合。骨折后3周的愈合率,通过放射学和组织学检查评估,在反义寡核苷酸存在下显著增加(50.9%,n=28/55)与对照组相比(正义寡聚DNA; 31.3%,n=16/51,突变的反义寡聚DNA; 28.6%,n=4/14,仅普朗尼克凝胶; 37.5%,n=6/16)。我们进一步构建了携带人钙调蛋白h1反义cDNA的腺病毒载体,用于抑制人间充质细胞中钙调蛋白mRNA的表达。
英文摘要
Myoblast differentiation into osteoblast induced by recombinant human BMP-2 (40 ng/ml) was enhanced by addition of anti-sense oligoDNA of mouse calponin h1 into the culture medium. Myoblast was prepared from the thigh muscle by trypsin digestion. Phosphothioate-modified anti-sense oligoDNA (18 mers) to the mouse calponin h1 sequence including the initiation codon was designed and synthesized. Treatment with the anti-sense oligoDNA but not with control oligoDNA at the concentrations of 80 μg/ml for 48 hr reduced the calponin h1 mRNA expression and 32.4±3.9% of the cells were differentiated into the osteogenic-lineage cells as demonstrated by the expression of alkaline phosphatase. We also demonstrated the accelerated healing of experimental bone fracture by local delivery of the anti-sense oligoDNA with the pluronic F127 gel at 48 h after bone fracture. The rate of union three weeks after fracture, as assessed by radiographic and histological examination, was significantly increased in the presence of the anti-sense oligoDNA (50.9%, n=28/55) as compared with control groups (sense oligoDNA ; 31.3%, n=16/51, mutated anti-sense oligoDNA ; 28.6%, n=4/14, pluronic gel only ; 37.5%, n=6/16). We further constructed adenovirus vector harboring anti-sense cDNA of human calponin h1 for inhibition of calponin mRNA expression in human mesenchymal cells.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
Youichi Sugenoya: "Smooth-muscle calponin in mesangial cells : Regulation of expression and a role in suppressing glomerulonephritis"J.Am.Soc.Nephrol.. 13. 322-331 (2002)
Youichi Sugenoya:“系膜细胞中的平滑肌钙调蛋白:表达调节和抑制肾小球肾炎的作用”J.Am.Soc.Nephrol.. 13. 322-331 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hisako Yamamura: "Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting of a conditionally replicating herpes vector to"Cancer Res.. 61. 3969-3977 (2001)
Hisako Yamamura:“人钙调蛋白启动子转录调控序列的鉴定及其在条件复制疱疹载体靶向中的应用”Cancer Res.. 61. 3969-3977 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matthew J.D.: "Contractile properties and proteins of a calponin knockout mouse."J.Physiol.(Lond.). 529. 811-824 (2000)
Matthew J.D.:“钙调蛋白敲除小鼠的收缩特性和蛋白质。”J.Physiol.(伦敦)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi K.: "Regualation of shortening velocity by calponin in intact contracting smooth muscles."Biochem.Biophys.Res.Commun.. 279. 150-157 (2000)
Takahashi K.:“完整收缩平滑肌中钙调素对缩短速度的调节。”Biochem.Biophys.Res.Commun.. 279. 150-157 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Molecular mechanisms for loss of contact inhibition in the cell motility of sarcoma and cancer invasion
    Characterization of sarcoma stem cells and development of the stem cell-targeting agents utilizing viral engineering
    Aiming at determination of the structure of oncolytic HSV-1 targeting to sarcoma and contruction of seed cell stock of virus-producing Vero designer cells for clinical application
    Development of targeted gene therapy for incurable sarcoma using a novel replication-selective and oncolytic viral vector
    海外基金